$722 Million is the total value of Integral Health Asset Management, LLC's 65 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 76.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | Buy | TENET HEALTHCARE CORP | $35,580,600 | +88.5% | 540,000 | +132.8% | 4.93% | +110.7% |
| ARGX | Buy | ARGENX SEsponsored adr | $34,414,100 | +120.8% | 70,000 | +75.0% | 4.76% | +146.8% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $29,040,000 | +15.2% | 550,000 | +18.0% | 4.02% | +28.8% |
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $28,500,000 | +86.3% | 500,000 | +66.7% | 3.95% | +108.3% | |
| CYTK | Buy | CYTOKINETICS INC | $23,568,000 | +11.2% | 800,000 | +23.1% | 3.26% | +24.3% |
| MDT | Buy | MEDTRONIC PLC | $23,508,000 | +233.5% | 300,000 | +275.0% | 3.25% | +272.7% |
| NARI | Buy | INARI MED INC | $22,890,000 | +154.0% | 350,000 | +125.8% | 3.17% | +184.0% |
| MCK | Sell | MCKESSON CORP | $21,742,500 | -29.3% | 50,000 | -30.6% | 3.01% | -21.0% |
| INSP | Buy | INSPIRE MED SYS INC | $20,836,200 | -37.7% | 105,000 | +1.9% | 2.88% | -30.3% |
| NVS | Buy | NOVARTIS AGsponsored adr | $20,372,000 | +96.0% | 200,000 | +94.2% | 2.82% | +119.1% |
| ABC | Buy | CENCORA INC | $19,796,700 | +295.7% | 110,000 | +323.1% | 2.74% | +342.1% |
| AMGN | New | AMGEN INC | $17,469,400 | – | 65,000 | +100.0% | 2.42% | – |
| CI | Sell | THE CIGNA GROUP | $17,164,200 | -66.0% | 60,000 | -66.7% | 2.38% | -62.0% |
| BDX | New | BECTON DICKINSON & CO | $16,804,450 | – | 65,000 | +100.0% | 2.33% | – |
| EHC | Buy | ENCOMPASS HEALTH CORP | $16,790,000 | +12.7% | 250,000 | +13.6% | 2.32% | +26.0% |
| DXCM | New | DEXCOM INC | $16,327,500 | – | 175,000 | +100.0% | 2.26% | – |
| Buy | VENTYX BIOSCIENCES INC | $14,933,900 | +30.1% | 430,000 | +22.9% | 2.07% | +45.5% | |
| RVMD | Buy | REVOLUTION MEDICINES INC | $14,532,000 | +52.6% | 525,000 | +47.5% | 2.01% | +70.7% |
| LLY | Sell | ELI LILLY & CO | $13,428,250 | -4.6% | 25,000 | -16.7% | 1.86% | +6.7% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $12,482,250 | +122.3% | 275,000 | +175.0% | 1.73% | +148.6% |
| MOH | New | MOLINA HEALTHCARE INC | $11,476,150 | – | 35,000 | +100.0% | 1.59% | – |
| TDOC | Buy | TELADOC HEALTH INC | $11,154,000 | +120.3% | 600,000 | +200.0% | 1.54% | +146.3% |
| PKI | Sell | REVVITY INC | $11,070,000 | -33.4% | 100,000 | -28.6% | 1.53% | -25.5% |
| AVTR | New | AVANTOR INC | $11,067,000 | – | 525,000 | +100.0% | 1.53% | – |
| ANTM | Sell | ELEVANCE HEALTH INC | $10,885,500 | -18.3% | 25,000 | -16.7% | 1.51% | -8.7% |
| SIBN | Buy | SI-BONE INC | $10,301,400 | +68.2% | 485,000 | +113.7% | 1.43% | +88.1% |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $10,200,000 | +35.5% | 1,000,000 | 0.0% | 1.41% | +51.5% | |
| GH | Sell | GUARDANT HEALTH INC | $9,633,000 | -34.7% | 325,000 | -21.1% | 1.33% | -26.9% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $9,562,500 | – | 85,000 | +100.0% | 1.32% | – |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $9,027,000 | -28.9% | 450,000 | 0.0% | 1.25% | -20.5% | |
| LFST | Buy | LIFESTANCE HEALTH GROUP INC | $8,931,000 | +26.5% | 1,300,000 | +68.2% | 1.24% | +41.4% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $8,856,000 | -25.2% | 800,000 | +9.6% | 1.23% | -16.3% |
| NTRA | New | NATERA INC | $8,850,000 | – | 200,000 | +100.0% | 1.22% | – |
| HOLX | Sell | HOLOGIC INC | $8,675,000 | -38.8% | 125,000 | -28.6% | 1.20% | -31.6% |
| New | MOONLAKE IMMUNOTHERAPEUTICSput | $8,550,000 | – | 150,000 | +100.0% | 1.18% | – | |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $8,407,520 | +317.9% | 748,000 | +274.0% | 1.16% | +367.5% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $8,120,000 | +11.6% | 70,000 | +12.9% | 1.12% | +24.8% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $7,855,400 | -82.0% | 70,000 | -76.7% | 1.09% | -79.9% |
| ALKS | Sell | ALKERMES PLC | $7,702,750 | -13.3% | 275,000 | -3.2% | 1.07% | -3.2% |
| CTLT | New | CATALENT INC | $7,284,800 | – | 160,000 | +100.0% | 1.01% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $7,251,750 | – | 275,000 | +100.0% | 1.00% | – |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $6,927,970 | -22.9% | 133,000 | -6.3% | 0.96% | -13.8% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $6,728,000 | -23.5% | 800,000 | +14.3% | 0.93% | -14.5% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $6,680,000 | – | 800,000 | +100.0% | 0.92% | – |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $6,065,400 | +169.0% | 220,000 | +193.3% | 0.84% | +201.1% |
| New | SAREPTA THERAPEUTICS INCcall | $6,061,000 | – | 50,000 | +100.0% | 0.84% | – | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $5,948,000 | – | 200,000 | +100.0% | 0.82% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $5,560,000 | – | 250,000 | +100.0% | 0.77% | – |
| New | ROIVANT SCIENCES LTD | $5,256,000 | – | 450,000 | +100.0% | 0.73% | – | |
| MRK | New | MERCK & CO INC | $5,147,500 | – | 50,000 | +100.0% | 0.71% | – |
| AKRO | Buy | AKERO THERAPEUTICS INC | $5,058,000 | +54.8% | 100,000 | +42.9% | 0.70% | +72.8% |
| CABA | New | CABALETTA BIO INC | $5,022,600 | – | 330,000 | +100.0% | 0.70% | – |
| PFE | New | PFIZER INC | $4,975,500 | – | 150,000 | +100.0% | 0.69% | – |
| COO | Sell | COOPER COS INC | $4,770,150 | -76.1% | 15,000 | -71.2% | 0.66% | -73.3% |
| REPL | Sell | REPLIMUNE GROUP INC | $4,277,500 | -58.6% | 250,000 | -43.8% | 0.59% | -53.7% |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $4,225,600 | -3.7% | 760,000 | +27.1% | 0.58% | +7.7% |
| NVST | ENVISTA HOLDINGS CORPORATION | $4,182,000 | -17.6% | 150,000 | 0.0% | 0.58% | -7.9% | |
| ZTS | New | ZOETIS INCcl a | $3,479,600 | – | 20,000 | +100.0% | 0.48% | – |
| New | 89BIO INCcall | $3,088,000 | – | 200,000 | +100.0% | 0.43% | – | |
| WW | New | WW INTL INC | $2,767,500 | – | 250,000 | +100.0% | 0.38% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $2,700,100 | – | 130,000 | +100.0% | 0.37% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,511,000 | – | 50,000 | +100.0% | 0.35% | – |
| HCA | Sell | HCA HEALTHCARE INC | $2,459,800 | -79.7% | 10,000 | -75.0% | 0.34% | -77.3% |
| SILK | New | SILK RD MED INC | $2,248,500 | – | 150,000 | +100.0% | 0.31% | – |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $1,147,000 | -81.9% | 100,000 | -60.0% | 0.16% | -79.7% |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -62,000 | -100.0% | -0.09% | – |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -180,000 | -100.0% | -0.20% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -412,000 | -100.0% | -0.25% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.26% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -52,000 | -100.0% | -0.26% | – |
| Exit | UNIQURE NVcall | $0 | – | -200,000 | -100.0% | -0.28% | – | |
| Exit | WALGREENS BOOTS ALLIANCE INCcall | $0 | – | -100,000 | -100.0% | -0.35% | – | |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -52,000 | -100.0% | -0.44% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -0.47% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -36,000 | -100.0% | -0.48% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -100,000 | -100.0% | -0.50% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -50,000 | -100.0% | -0.54% | – |
| CCRN | Exit | CROSS CTRY HEALTHCARE INC | $0 | – | -155,000 | -100.0% | -0.54% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -387,000 | -100.0% | -0.60% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -200,000 | -100.0% | -0.65% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.77% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -72,000 | -100.0% | -0.81% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -174,000 | -100.0% | -0.88% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -88,000 | -100.0% | -1.02% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -206,000 | -100.0% | -1.04% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -52,000 | -100.0% | -1.22% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -30,000 | -100.0% | -1.28% | – |
| SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -250,000 | -100.0% | -1.39% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -72,000 | -100.0% | -1.48% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -50,000 | -100.0% | -1.49% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -120,000 | -100.0% | -1.52% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -36,000 | -100.0% | -1.52% | – |
| Exit | GSK PLCsponsored adr | $0 | – | -350,000 | -100.0% | -1.54% | – | |
| SDGR | Exit | SCHRODINGER INC | $0 | – | -265,000 | -100.0% | -1.64% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -100,000 | -100.0% | -1.67% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -200,000 | -100.0% | -1.67% | – |
| Exit | NOVO-NORDISK A Sput | $0 | – | -250,000 | -100.0% | -5.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.